MXPA05003327A - Proceso e intermediarios para la preparacion de derivados de tienopirrol. - Google Patents

Proceso e intermediarios para la preparacion de derivados de tienopirrol.

Info

Publication number
MXPA05003327A
MXPA05003327A MXPA05003327A MXPA05003327A MXPA05003327A MX PA05003327 A MXPA05003327 A MX PA05003327A MX PA05003327 A MXPA05003327 A MX PA05003327A MX PA05003327 A MXPA05003327 A MX PA05003327A MX PA05003327 A MXPA05003327 A MX PA05003327A
Authority
MX
Mexico
Prior art keywords
carbon atoms
alkyl
formula
carbamoyl
amino
Prior art date
Application number
MXPA05003327A
Other languages
English (en)
Spanish (es)
Inventor
Stephen Parker Jeremy
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MXPA05003327A publication Critical patent/MXPA05003327A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
MXPA05003327A 2002-10-03 2003-09-29 Proceso e intermediarios para la preparacion de derivados de tienopirrol. MXPA05003327A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0222912.8A GB0222912D0 (en) 2002-10-03 2002-10-03 Novel process and intermediates
PCT/GB2003/004217 WO2004031194A1 (en) 2002-10-03 2003-09-29 Process and intermediates for the preparation of the thienopyrrole derivatives

Publications (1)

Publication Number Publication Date
MXPA05003327A true MXPA05003327A (es) 2005-07-05

Family

ID=9945219

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05003327A MXPA05003327A (es) 2002-10-03 2003-09-29 Proceso e intermediarios para la preparacion de derivados de tienopirrol.

Country Status (13)

Country Link
US (1) US7411074B2 (enExample)
EP (1) EP1549654A1 (enExample)
JP (1) JP2006505541A (enExample)
KR (1) KR20050061503A (enExample)
CN (1) CN100378106C (enExample)
AU (1) AU2003269219A1 (enExample)
BR (1) BR0314966A (enExample)
CA (1) CA2500145A1 (enExample)
GB (1) GB0222912D0 (enExample)
MX (1) MXPA05003327A (enExample)
NO (1) NO20051393L (enExample)
WO (1) WO2004031194A1 (enExample)
ZA (1) ZA200502340B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
AU2004312530A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
JP5420534B2 (ja) 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU364613A1 (ru) * 1970-11-27 1972-12-28 Всесоюзный научно исследовательский химико фармацевтический институт имени С. Орджоникидзе Способ получения производных 2-аминотиено-
JPH01242587A (ja) * 1988-03-25 1989-09-27 Sankyo Co Ltd 縮環オキサゾロチエノピリミジン誘導体
GB9302622D0 (en) 1993-02-10 1993-03-24 Wellcome Found Heteroaromatic compounds
ES2211454T3 (es) 1999-09-30 2004-07-16 Pfizer Products Inc. Pirrolilamidas como inhibidores de la colageno fosforilasa.
ATE290865T1 (de) 1999-10-19 2005-04-15 Merck & Co Inc Tyrosin kinase inhibitoren
SE9903998D0 (sv) 1999-11-03 1999-11-03 Astra Ab New compounds
JP2001294572A (ja) 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
EP1136071A3 (en) 2000-03-22 2003-03-26 Pfizer Products Inc. Use of glycogen phosphorylase inhibitors
GB0017676D0 (en) 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
MXPA03000966A (es) 2002-02-28 2003-09-04 Pfizer Prod Inc Agentes antidiabeticos.
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
JPWO2003091213A1 (ja) 2002-04-25 2005-09-02 アステラス製薬株式会社 新規なアミド誘導体又はその塩
US7226938B2 (en) 2002-09-06 2007-06-05 Janssen Pharmaceutica, N.V. Heterocyclic compounds
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
MXPA05004968A (es) 2002-11-07 2005-08-02 Pfizer Prod Inc N-(indol-z-carbonil)amidas como agentes anti-diabeticos.
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
JP2004196702A (ja) 2002-12-18 2004-07-15 Yamanouchi Pharmaceut Co Ltd 新規なアミド誘導体又はその塩
WO2004058715A1 (ja) 2002-12-25 2004-07-15 Daiichi Pharmaceutical Co., Ltd. ジアミン誘導体
WO2004092158A1 (en) 2003-04-17 2004-10-28 Pfizer Products Inc. Carboxamide derivatives as anti-diabetic agents
BRPI0409952A (pt) 2003-04-30 2006-04-25 Pfizer Prod Inc agentes anti-diabéticos
WO2004113345A1 (ja) 2003-06-20 2004-12-29 Japan Tobacco Inc. 縮合ピロール化合物及びその医薬用途
GB0318463D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0318464D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
GB0319690D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
WO2005020985A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
WO2005020986A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
GB0320422D0 (en) 2003-08-30 2003-10-01 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
CN100378106C (zh) 2008-04-02
NO20051393L (no) 2005-04-20
KR20050061503A (ko) 2005-06-22
US7411074B2 (en) 2008-08-12
AU2003269219A1 (en) 2004-04-23
BR0314966A (pt) 2005-08-02
JP2006505541A (ja) 2006-02-16
CA2500145A1 (en) 2004-04-15
ZA200502340B (en) 2005-09-19
GB0222912D0 (en) 2002-11-13
WO2004031194A1 (en) 2004-04-15
US20060035953A1 (en) 2006-02-16
CN1688587A (zh) 2005-10-26
EP1549654A1 (en) 2005-07-06

Similar Documents

Publication Publication Date Title
EP2546256B1 (en) Process for the synthesis of E1 activating enzyme inhibitors
MXPA05003327A (es) Proceso e intermediarios para la preparacion de derivados de tienopirrol.
US7307174B2 (en) Process and intermediates for the preparation of thienopyrrole derivatives
WO2007082131A1 (en) Process for the preparation of hydroxy substituted heterocycles
ITMI961732A1 (it) Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze e in particolare dell'alcoolismo
IE83508B1 (en) Quinoxalines, processes for their preparation, and their use
WO1994029310A1 (en) Process for asymmetric total synthesis of camptothecin
EP1440075A1 (fr) Nouveaux derives amides heteroaromatiques de 3beta-amino azabicyclooctane, leur procede de preparation et leurs applications en therapeutique
HUT54162A (en) Process for producing new substituted thienopyran derivatives and pharmaceutical compositions comprising such compounds
Kumar et al. Synthesis of some novel 1, 2, 4-triazolo [4, 3-a] 2h-pyrano [3, 2-e] pyridine derivatives
RU2323939C1 (ru) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ПИРРОЛО[1,2-а][1,4]ДИАЗЕПИНА
SG182370A1 (en) Method for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof
Juršić et al. The selective methylation of 4-ethoxycarbonyl-3-methylpyrazolin-5-one with dimethyl sulfate
Boulouard et al. Pyirolothieno [1, 4] diazepines. Part IV. First synthesis of pyrrolo‐[1, 2‐a] thieno [2, 3‐f][1, 4] diazepine Derivatives
Puterová et al. Synthesis of novel water soluble onium salts and thieno [3, 4-c] thiolactones–precursors of conductive materials derived from substituted 2-aminothiophenes
CN120757602A (zh) 一种具有治疗骨质疏松活性的雷公藤红素衍生物及其制备方法和应用
RU2649006C2 (ru) Способ синтеза гидразина, который можно применять при лечении вируса папилломы
CN118005593A (zh) 一种2,3-二取代色酮类化合物的制备方法
JP4745315B2 (ja) ３−アミノチオフェン誘導体
RU2417995C1 (ru) Способ получения 3-(2-замещенных-1,3-оксазол-4-ил)пиридин-2(1н)-онов
Kumar et al. E-mail: vknalam@ vahoo. com
EA002723B1 (ru) Способы и промежуточные продукты, полезные для получения антифолатов
JP2008543761A (ja) ３−アミノ−４−置換ピラゾール誘導体の合成
HK1178895B (en) Process for the synthesis of e1 activating enzyme inhibitors
MXPA00007824A (enExample)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal